Role of Valproate in Managing Aggression in Substance Use Disorder

Evidence for Valproate in Aggression Management

The American Academy of Child and Adolescent Psychiatry suggests that controlled clinical trials indicate mood stabilizers such as divalproex sodium (valproate) show promise for treating aggressive behavior, particularly when used as part of a comprehensive treatment approach 1

The American Academy of Child and Adolescent Psychiatry recommends implementing psychosocial interventions including functional family therapy and multi-systemic therapy before considering medication 1
Valproate should be considered for patients with persistent aggression despite psychosocial interventions, when aggression is severe and poses safety risks, or in patients with comorbid bipolar features or mood instability 1, 2, 3, 4

The American Academy of Child and Adolescent Psychiatry states that medications for aggression should be considered adjunctive, palliative, and non-curative; they should not be the sole intervention 1
A strong treatment alliance should be established before starting medication trials, and non-responsiveness to valproate should lead to a trial of another class of medication rather than rapid addition of other medications 1
Regular monitoring of liver function is necessary due to rare but serious hepatotoxicity risk 4

The American Academy of Child and Adolescent Psychiatry recommends that in patients with comorbid conditions, medication should target specific syndromes when possible 1
For patients who fail to respond to valproate, a switch to an atypical antipsychotic may be considered, and valproate may have advantages over other medications in patients with intellectual disability due to lower risk of behavioral adverse effects 1, 2, 4, 5